← Research ProtocolsGHRP-6
STUDIED EXPOSURE MAP / 2013
GHRP-6
tested in research.
The actual doses, concentrations or exposure levels reported by the source — kept attached to route, population, timeframe and evidence type.
HUMAN / PHARMACOKINETICEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESSTUDIED EXPOSURE ≠ RECOMMENDED DOSE
STUDIED EXPOSURE / SOURCE DATANumbers below describe this research source only.
100 µg/kg
single IV bolus
200 µg/kg
single IV bolus
400 µg/kg
single IV bolus
Context: These are high, weight-normalized IV research exposures in a pharmacokinetic study. They are not equivalent to non-IV administration.
NOT A DOSING GUIDEENHANCED is reporting what researchers administered or tested. It does not convert these numbers into a personal dose, reconstitution plan, cycle, titration schedule or recommendation.
SOURCE / EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 in nine healthy male volunteers
Study design and tested exposure are separated from recommendation. Route and population stay visible so the numbers cannot be read without context.
2013
01 / DESIGNClinical pharmacokinetic dose study
02 / POPULATION / MODEL9 healthy male volunteers
03 / ROUTESingle intravenous bolus
04 / TIMEFRAMEAcute PK sampling
05 / PRIMARY QUESTIONPlasma pharmacokinetics of GHRP-6
It supports a factual statement about the exposure tested in this research source. It does not establish that the same exposure is appropriate, effective or safe outside that source.
Broader research index. This entity is not presented here as an ENHANCED catalogue compound.
Study exposure ≠ personal protocol. Animal doses are never converted to human-equivalent amounts here. IV, topical, oral, intranasal and subcutaneous exposures are not treated as interchangeable.